Version 2.78

Description

Vaborbactam is a beta-lactamase inhibitor in the new cyclic boronic acid class of inhibitors that is being developed in combination with meropenem. It has activity against serine carbapenemases, especially Klebsiella pneumonia carbapenemase (KPC), and the meropenem-vaborbactam combination is effective against KPC-producing strains of Enterobacteriaceae. It has been studied as a treatment of complicated urinary tract infection, acute pyelonephritis, and other infections due to carbapenem-resistant Enterobacteriaceae, including hospital-acquired and ventilator-associated pneumonia PMID: 27527080 In August 2017, meropenem-vaborbactam was approved by the U.S. FDA for the treatment of complicated urinary tract infections, including pyelonephritis. Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Meropenem+Vaborbactam
Part Type
Component (Describes the core component or analyte measured)
Created On
2017-01-12
Construct for LOINC Short Name
Mero+Vab

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP247822-2

Language Variants Get Info

Tag Language Translation
es-ES Spanish (Spain) Meropenem+Vaborbactam
zh-CN Chinese (China) 美罗培南+伐波巴坦
Synonyms: 美罗培南(美洛培南)+伐波巴坦(Vaborbactam、瓦波巴坦);CAS 1360457-46-0;RPX7009;RPX-7009;RPX 7009
it-IT Italian (Italy) Meropenem+Vaborbactam
nl-NL Dutch (Netherlands) meropenem + vaborbactam
fr-CA French (Canada) Méropénem+Vaborbactam